The importance of uninterrupted albendazole treatment in patients with unresectable alveolar echinococcosis undergoing liver transplantation

This study focused on the monitoring of patients who had undergone liver transplantation (LT) because of unresectable alveolar echinococcosis (AE). The role of long‐term administration of albendazole (ABZ) in patients with residual/recurrent AE lesions and without AE lesions was evaluated.

[1]  Xianwei Yang,et al.  Transhepatic-intrahepatic branches of the portal vein catheterization for ex vivo liver resection and autotransplantation , 2019, Medicine.

[2]  S. Eslami,et al.  Liver transplantation for hepatic alveolar echinococcosis: literature review and three new cases , 2018, Infectious diseases.

[3]  I. Kolyshev,et al.  Liver Transplantation for Unresectable Hepatic Alveolar Echinococcosis , 2017 .

[4]  V. Sergiev,et al.  [Alveolar echinococcosis in European Russia]. , 2013, Meditsinskaia parazitologiia i parazitarnye bolezni.

[5]  F. Grenouillet,et al.  Should possible recurrence of disease contraindicate liver transplantation in patients with end‐stage alveolar echinococcosis? A 20‐year follow‐up study , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  R. Piarroux,et al.  Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  H. Karakayalı,et al.  Liver transplantation in management of alveolar echinococcosis: two case reports. , 2009, Transplantation proceedings.

[8]  D. Vuitton.  Benzimidazoles for the treatment of cystic and alveolar echinococcosis: what is the consensus? , 2009, Expert review of anti-infective therapy.

[9]  W. Kratzer,et al.  WHO classification of alveolar echinococcosis: principles and application. , 2006, Parasitology international.

[10]  L. Bachmann,et al.  Evaluation of treatment and long‐term follow‐up in patients with hepatic alveolar echinococcosis , 2005, The British journal of surgery.

[11]  A. Buck,et al.  Structured treatment interruption in patients with alveolar echinococcosis , 2004, Hepatology.

[12]  G. Mantion,et al.  Experience of liver transplantation for incurable alveolar echinococcosis: a 45-case European collaborative report , 2003, Transplantation.

[13]  Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis. , 1996, Bulletin of the World Health Organization.

[14]  A. Freiburghaus,et al.  Effect of chemotherapy on the larval mass and the long‐term course of alveolar echinococcosis , 1994, Hepatology.